AMGN vs BIIB: Which Stock is Better?

Side-by-side comparison of Amgen Inc and Biogen Inc in 2026

Comparison Updated:

AMGN

Amgen Inc

$377.00

BIIB

Biogen Inc

$184.02

Key Metrics Comparison

MetricAMGNBIIBWinner
Market Cap$203.23B$27.01BAMGN
P/E Ratio26.5321.42BIIB
EPS (TTM)$14.21$8.59AMGN
Revenue Growth0.1%-0.1%AMGN
Gross Margin70.8%78.9%BIIB

Analyze AMGN

Full quant analysis

Analyze BIIB

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is AMGN or BIIB a better investment?

Comparing AMGN and BIIB: Amgen Inc has a market cap of $203.23B while Biogen Inc has $27.01B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between AMGN and BIIB?

AMGN (Amgen Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: AMGN or BIIB?

Based on P/E ratios, BIIB trades at a lower multiple (21.4x vs 26.5x).

Which is growing faster: AMGN or BIIB?

AMGN has higher revenue growth at 0.1% vs -0.1% for BIIB.

Which company is more profitable: AMGN or BIIB?

Biogen Inc (BIIB) has higher gross margins at 78.9% compared to 70.8% for AMGN.

Which is the larger company: AMGN or BIIB?

Amgen Inc (AMGN) is larger with a market cap of $203.23B compared to $27.01B for BIIB.

Should I buy AMGN or BIIB in 2026?

Both AMGN and BIIB have investment merit. AMGN trades at $377.00 while BIIB trades at $184.02. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between AMGN and BIIB stock?

Key differences: Market Cap ($203.23B vs $27.01B), P/E Ratio (26.5x vs 21.4x), Revenue Growth (0.1% vs -0.1%), Gross Margin (70.8% vs 78.9%).

Popular Stock Comparisons